Background: Deletion of the subtelomeric region of 1p36 is one of the most common subtelomeric deletion syndromes. In monosomy 1p36, the presence of obesity is poorly defined, and glucose metabolism deficiency is rarely reported. However, the presence of a typical Prader-Willi-like phenotype in patients with monosomy 1p36 is controversial.
Background
Deletion of the subtelomeric region of 1p36 is one of the most common subtelomeric deletion syndromes, with an estimated incidence of 1 in 5000 to 1 in 10,000 live births [1] [2] [3] . The four classes of rearrangements identified in individuals with monosomy 1p36 in order of frequency are as follows: apparently pure/simple terminal deletions (67%), derivative chromosomes (16%), interstitial deletions (10%), and complex rearrangements (7%) [4] .
Monosomy 1p36 is responsible for a cluster of characteristic clinical features including mental retardation and multiple congenital abnormalities caused by haploinsufficiency of numerous contiguous genes [1] , such as deep-set eyes, straight eyebrows positioned low on the supra-orbital ridges, asymmetric ears, a pointed chin, and a flat nasal bridge [1] . Additional features include cardiomyopathy, hearing impairment, seizures [5, 6] , and a variety of neoplasms due to the loss of numerous tumour-suppressor genes that are located in this chromosomal region [7, 8] .
In monosomy 1p36, the occurrence of both obesity and or glucose metabolism disorders is rarely reported. However, the presence of a typical Prader-Willi-like phenotype in patients with 1p36 monosomy is controversial.
Case presentation
In this report, we describe two female subjects with monosomy 1p36 and Prader-Willi-like phenotype who also exhibit type II diabetes and impaired glucose tolerance due to hyperinsulinism. We provide data both for and against this possible association. Written informed consent was obtained from the parents before publication of this case report and any accompanying images.
Clinical report 1
A female patient, 6 years 2 months of age, was referred to our Paediatric Endocrinology Unit for severe obesity.
The proposita was the third-born child (the first pregnancy was interrupted because of a disorder involving chromosome 7) of a nonconsanguineous marriage who was delivered normally at 40 weeks after an uncomplicated pregnancy. The family history was unremarkable, particularly for obesity, which was present only in a paternal uncle. The Apgar score was 5 th centile), and the pubertal staging was defined as B1-PH2-3-AH2. Her blood pressure evaluation showed both systolic and diastolic hypertension (124/85 mmHg).
Numerous dysmorphic features were observed, including a small mouth with heaped-up palate, a small chin, a small folded ear, straight eyebrows, fifth finger clinodactyly and short toes. Examination of the subject's mother revealed some mild dysmorphism, clinodactyly of the fifth finger and a mild learning disability ( Figure 1a ; Table 1 ).
Assessment of basal hormone levels showed normal free thyroxine (1.63 ng/dL; range 0.8-1.9), TSH (3.51 μIU/mL; range, 0.4-4.0), cortisol (12.3 μg/dL; range [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and ACTH (21.1 ng/L; range 9.0-52.0) values. The blood count was also normal. Her blood chemistry was AST: 45 IU/L, ALT: 35 IU/L, γ-GTP: 27 IU/L, HbA1c: 6.1%, TG: 132 mg/dL, total cholesterol: 195 mg/dL, HDL: 51 mg/dL, insulin: 54.5 μU/ml, glycaemia: 102 mg/dl (HOMA 13.72). A screening for coeliac disease was negative (IgA 142 mg/dl; tTG 0.2 U/ mL), but an oral glucose tolerance test indicated hyperinsulinism (peak insulin level was 297 μU/mL), impaired glucose tolerance (120' glycaemia 179 mg/dl), and marked insulin resistance (120' insulin level 193 μU/mL).
Routine cytogenetic investigations revealed an apparently normal female karyotype (46, XX). Chromosomal studies, also using FISH, ruled out a 15q11.2-q13 deletion. Tests for methylation and the presence of maternal uniparental disomy were both negative.
Given the numerous clinical features observed in this subject, a FISH analysis utilising 41 subtelomere probes was performed (Genzyme laboratories (Hawthorne, NY)) using Vysis probes (Downers Grove, IL). The results were confirmed with a chromosome 1p subtelomere probe (1pSUBTEL; Vysis) and the D1Z2 midi-satellite probe with repeats in band 1p36 (Oncor), which is used to confirm a common deletion interval (1p36.3).
Molecular karyotyping was performed by an array-CGH analysis using the proband's DNA and an Agilent 44 K array platform with a resolution of approximately 100 kb. 
Clinical report 2
The female patient, 10 years 1 month of age, was referred to the Genetics and Molecular Medicine Unit of Anna Meyer Children's University Hospital for severe obesity and suspected Prader-Willi syndrome.
The proposita was the second-born child of a nonconsanguineous marriage who was delivered normally at 39 weeks after an uncomplicated pregnancy. The family history was unremarkable in terms of obesity. The patient has a brother with normal staturo-ponderal growth who was 6 yrs old at the time of this study.
The Apgar score was 6
; as an infant, she required oral suctioning, oxygen and stimulation at delivery for treatment of cyanosis. Her birth weight was 2.360 kg (-1.92 SDS; <3 rd centile), her length was 44.6 cm (-2.24 SDS; <3 rd centile), and her head circumference was 32 cm (-1.90 SDS; <3 rd centile). Central hypotonia occurred soon after birth. The screening for neonatal congenital hypothyroidism was negative, but she experienced recurrent respiratory infections throughout the first year of life.
At 6 months of age, persistence of patent ductus arteriosus (PDA), which lead to pulmonary hypertension, was diagnosed; PDA was closed at 7 months. She presented with abnormal psychomotor development, as she began to sit upright at 9 months, walk independently at 17 months and demonstrated use of language at 19 months. Bilateral neurosensory deafness was diagnosed at 1 year of age. The child developed significant hyperphagia. At 10 yrs 1 month of age, the proposita showed a phenotype consistent with Prader-Willi syndrome: the patient weighed 52.600 kg (1.65 SDS; 90-97 th centile), her length was 131.8 cm (-1.18 SDS; 10 th centile), and her BMI was 27.7 (2.02 SDS; > > 97 th centile). The pubertal staging was defined as B1-PH2-3-AH2. Blood pressure evaluation showed systolic and diastolic hypertension (124/85 mmHg).
At the evaluation, she was observed to have numerous dysmorphic features, including substantial truncular obesity, scoliosis, small hands and feet, a small mouth with heaped-up palate, a small chin and a small folded ear, straight eyebrows, fifth finger clinodactyly and short toes, and a mild learning disability. Examination of the mother revealed some mild dysmorphism, clinodactyly of the fifth finger, and a mild learning disability (Figure 1b ).
An analysis of basal hormone levels showed normal free thyroxine (13. Routine cytogenetic investigations revealed an apparently normal female karyotype (46, XX). Chromosomal studies, which also used FISH, ruled out a 15q11.2-q13 deletion found in Prader-Willi syndrome. The hypophyseal RMN revealed an empty sella.
At 12 yrs, 8 months, her height was 141 cm (-2.10 SDS; < 3 rd centile), BMI was 29.9 (2.18 SDS; > 97 th centile), and pubertal staging was described as B2-3-PH4-AH2. Menarche started at 13 years of age.
At 16 years of age, her height was 145 cm (-2.82 SDS; < 3 rd centile), her weight was 56.000 kg (0.05 SDS; 50-75 th centile), and pubertal staging was found to be B5-PH5-AH3.
Tests for methylation and the presence of maternal uniparental disomy were both negative. Therefore, given the numerous clinical features observed in this subject, a FISH analysis utilising 41 subtelomere probes was performed (Genzyme laboratories (Hawthorne, NY), using Vysis probes (Downers Grove, IL). The results were confirmed with a chromosome 1p subtelomere probe (1pSUBTEL; Vysis) and the D1Z2 midi-satellite probe with repeats in band 1p36 (Oncor). The D1Z2 probe is used for the confirmation of a common deletion interval (1p36.3). Array-CGH was performed using the Agilent Human Genome CGH microarray kit 180 K, with a resolution of approximately 40 kb. Break point positions were reported according to Hg19, with build 37 falling between 564,424 bp (first-deleted oligomer) and 3,111,905 bp (last-deleted oligomer), which showed a deletion of approximately 2.5 Mb that involved the 1p36.33 -1p36.32 region (Figure 2b ). 
Conclusion
Monosomy 1p36 is a common deletion syndrome that produces specific physical characteristics, such as distinctive facial anomalies (pointed chin, flat nose, low-set ears), cardiovascular malformations (atrial septal defect, patent ductus arteriosus, tetralogy of Fallot), central nervous system defects (mental retardation, cranial nerve abnormalities, sensorineural hearing loss), neonatal hypotonia, cortical dysplasia, and seizures [2, 9, 10] . Affected individuals can display outbursts, a tendency towards violent and self-injurious behaviour, as well as autistic-like behaviours [5] .
In patients with monosomy 1p36, the presence of obesity has been poorly defined, and glucose metabolism disorders have been infrequently reported to date. For example, D'Angelo et al. [11] identified 1 case of diabetes in a 13-year old patient, from within a group of 41 patients with a Prader-Willi-like phenotype, who had a pure 1p36 deletion. However, a study that evaluated the glucose metabolism in subjects with 1p36 deletion syndrome had not been performed until our current study.
Our case reports confirm this association and suggest that this phenotype may be associated with obesity in some 1p36 patients. We also present evidence that hyperinsulinism and impaired glucose tolerance or diabetes mellitus may be present in these patients and that these features can occur in younger patients.
In fact, genome-wide linkage studies suggest that the 1p36 region shows a strong correlation with several traits normally associated with metabolic syndrome (MetS) [12] , such as hyperlipidaemia, diabetes, obesity, arterial hypertension, and BMI cluster [13, 14] .
Prader-Willi-like phenotype has been described in patients with chromosomal duplications [15, 16] , Fragile X syndrome [17] , udp (14) mat [18, 19] , and 6q deletion syndrome [20] .
Obesity and/or hyperphagia are features rarely described in patients with 1p 36 deletion [1, 11, [21] [22] [23] [24] , but correlations between the extents of the deleted chromosomal segments have not been comprehensively provided. A hypothesis for the similarity between patients with a 1p36 deletion and those with Prader-Willi syndrome, as well as for the existence of two different phenotypes for a 1p36 microdeletion, has been suggested [23] . Contrary to its manifestation in 1p36 deletion syndrome, obesity is a common clinical sign associated with mental retardation, and is clearly a public health problem. Thus, a suitable question to ask is whether these patients, who were described as being obese, are really representative of this particular deletion syndrome [25] .
To help paediatric neurologists and other professionals in the recognition of this emerging and common chromosomal syndrome and to identify the possible overlap of clinical presentations between patients with 1p36 deletion syndrome and patients with a Prader-Willi like phenotype, we have reviewed published articles that describe patients with these features. D'angelo et al. [23] described samples from 26 patients with Prader-Willi-like phenotype that were analysed with a 1p-specific subtelomeric probe, where one terminal deletion was identified in one patient. This patient did not have any of the obvious features that resembled this monosomy, but her clinical and behavioural features were quite similar to those observed in patients with PWS, except for the presence of normal sucking at birth. The extent of the deletion could be limited to the mostterminal 2.5 Mb of 1p36, within the chromosomal region 1p36.33-1p36.32, that is smaller than that usually observed in monosomy 1p36 patients. Slavotinek et al. [5] reviewed 39 cases reported to have pure 1p36 deletions and 2 cases (5.1%) that demonstrated the PraderWilli-like phenotype. Shapira et al. [1] described 13 cases of the pure 1p36 deletion and found 2 cases (15%) of obesity. Therefore, chromosome 1p36.33 deletion should be investigated in patients with hypotonia, developmental delay, obesity and/or hyperphagia and behavioural problems who test negative for PWS, which might suggest non-classical manifestations of this disorder in these patients [23] .
Thus far, no individual gene within this region has been conclusively determined to be causative of any component of the phenotype [23] . However, in patients with 1p36 deletion syndrome and PWS-like phenotype, the possible involvement of the terminal 4 Mb of chromosome 1p36 may be postulated [24] .
Interestingly, D' Angelo et al. [23] have found that some genes located near 1p36 may be involved in carbohydrate or lipid metabolism or insulin signalling. Some of these genes may be implicated in the Prader-Willi-like phenotype typical of some monosomy 1p36 patients through a mechanism of either haploinsufficiency, position effect or gene interactions (epistasis) [23] . This may be important because the 1p34 -36 region has shown significant genome-wide linkage to premature myocardial infarction [26] .
Approximately 90% of the 1p rearrangements are less than 10 Mb in size [3] , and it is assumed that quite a number of subjects are misdiagnosed [3] . Moreover, several subjects diagnosed with monosomy 1p36 have been reported to have mild or atypical phenotypes or presenting features that overlap with other genetic syndromes [11, [27] [28] [29] .
In conclusion, our case reports confirm that some patients with 1p36 monosomy may show a Prader-Willi-like physical phenotype and that this aspect may therefore be overlooked, which may result in this condition being underdiagnosed. These patients may show such characteristics as obesity with hyperinsulinism and impaired glucose metabolism. Further studies are necessary to further evaluate this aspect.
Consent statement
Written informed consent was obtained from the parents of the patients for publication of this case report and any accompanying images.
